Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Shengjie LuKoon Gee Neoh

Abstract

Synergistic effect against UMUC3 bladder cancer cells was demonstrated via a "two-in-one" combination of doxorubicin (Dox) and peptide-modified cisplatin (Pt-ALy) loaded in positively charged mucoadhesive chitosan-polymethacrylic acid (CM) nanocapsules. The in vitro killing efficacy of the dual drug-loaded nanocapsules (CM-Dox-PtALy) against UMUC3 cells after 4h- and 72h-treatment is much higher (with 5-16 times lower IC50) than either Dox- or Pt-ALy-loaded nanocapsules, resulting in combination indexes of much less than 1 (i.e. obvious synergism) at fractions of affected cells ranging from 0.2 to 0.8. The dose reduction index of Pt-ALy for 72h-treatment is higher than for 4h-treatment, suggesting that Dox in CM-Dox-PtALy played a more significant role in the synergy in the former. The drug-loaded CM nanocapsules are readily taken in by the cells as shown by flow cytometry, confocal laser scanning microscopy and inductively coupled plasma mass spectrometry. Microscopy observations indicate that CM nanocapsules attach strongly on the luminal surface of the bladder with no obvious damage of the urothelium, supporting our objective of prolonging the dwell time of the drug-loaded nanocapsules for intravesical applications. Our stud...Continue Reading

References

Dec 22, 1999·International Journal of Pharmaceutics·A Bernkop-Schnürch
Mar 17, 2001·Advanced Drug Delivery Reviews·H TakeuchiY Kawashima
Sep 29, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·I M van der LubbenH E Junginger
Jul 5, 2003·The Journal of Pharmacy and Pharmacology·Yong Woo ChoKinam Park
Oct 2, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Tate ThigpenShu Liao
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liang ZhaoJessie L-S Au
Mar 2, 2005·Nature Reviews. Cancer·Mauro Ferrari
Oct 4, 2005·Advanced Drug Delivery Reviews·John D Smart
Feb 9, 2006·Nature Biotechnology·David Lane
Feb 24, 2006·International Journal of Pharmaceutics·Sakchai Wittaya-areekulChureerat Prahsarn
Aug 2, 2006·Biological & Pharmaceutical Bulletin·Mojca Kerec KosAles Mrhar
Aug 8, 2006·Molecular Pharmaceutics·Pradeep TyagiLeaf Huang
Nov 10, 2006·Advanced Drug Delivery Reviews·Vladimir P Torchilin
Jul 13, 2007·Nature Reviews. Cancer·Lloyd Kelland
Jan 22, 2008·International Journal of Pharmaceutics·Jringjai Thongborisute, Hirofumi Takeuchi
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kwangjae ChoDong M Shin
Mar 29, 2008·Pharmaceutical Research·Zancong ShenJessie L-S Au
Apr 4, 2008·BJU International·Boris A HadaschikMartin E Gleave
Sep 2, 2008·Nature Reviews. Drug Discovery·Mark E DavisDong M Shin
Sep 18, 2008·Histochemistry and Cell Biology·Peter VeranicKristijan Jezernik
Nov 6, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Gavin P AndrewsDavid S Jones
Feb 17, 2009·World Journal of Urology·Martine PloegLambertus A Kiemeney
Jun 23, 2009·Expert Opinion on Drug Delivery·M WirthF Gabor
Aug 25, 2009·Advanced Drug Delivery Reviews·Francesca Greco, María J Vicent
Oct 15, 2009·International Journal of Pharmaceutics·C E Mora-HuertasA Elaissari
Mar 30, 2010·Expert Opinion on Therapeutic Patents·Neeraj MishraSuresh P Vyas
Sep 14, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shruti GuhaSarkar, R Banerjee
Nov 17, 2010·Journal of the American Chemical Society·Sang-Min LeeSonBinh T Nguyen
Jan 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas Bachleitner-HofmannMartin R Weiser
Mar 2, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Clement MugabeHelen M Burt
Jul 6, 2011·International Journal of Pharmaceutics·Jan BarthelmesAndreas Bernkop-Schnürch
Aug 21, 2013·Biomaterials·Jinrong PengZhiyong Qian

❮ Previous
Next ❯

Citations

Oct 26, 2016·Colloids and Surfaces. B, Biointerfaces·Jakarwan YostawonkulUracha Rungsardthong Ruktanonchai
Jan 31, 2018·Frontiers in Pharmacology·Julieti Huch BussFabiana Kömmling Seixas
May 8, 2018·Expert Opinion on Emerging Drugs·Jasper Crijnen, Theo M De Reijke
Feb 20, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gang LiIjeoma F Uchegbu
Dec 13, 2016·Biomacromolecules·Bapurao Surnar, Manickam Jayakannan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Related Papers

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Shengjie LuEdmund Chiong
© 2022 Meta ULC. All rights reserved